Skip to content

The Dissemination of Consensus Recommendations on Upper Gastrointestinal Bleeding

The Dissemination of Consensus Recommendations on the Management of Canadian Patients With Non Variceal Upper Gastrointestinal Bleeding: A National Cluster Randomized Trial of a Multifaceted Tailored Implementation Strategy

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00840008
Acronym
REASON-II
Enrollment
3157
Registered
2009-02-10
Start date
2008-09-30
Completion date
2010-12-31
Last updated
2011-08-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Peptic Ulcer Hemorrhage

Keywords

peptic ulcer bleeding, upper GI hemorrhage, adherence to guidelines, knowledge transfer

Brief summary

The purpose of this study is to assess whether adherence to NVUGIB guidelines is improved with implementation of a national, tailored multifaceted intervention. Outcomes include adherence rates to two key endoscopic and pharmacological therapy guidelines together (primary), or adherence to these individually as well as to other recommendations (secondary). Patient outcomes and economic data are also assessed (tertiary).

Detailed description

Clusters are randomized to receive a published algorithm and guidelines (control group), or a multifaceted, tailored educational intervention (see details in protocol - intervention group). The charts of treated patients with non variceal upper GI bleeding are reviewed and adherence to selected guidelines recorded.

Interventions

OTHEREducational intervention

As per detailed protocol.

Sponsors

Horizon Health Network
CollaboratorOTHER
Queen Elizabeth II Health Sciences Centre
CollaboratorOTHER
St-Johns Health Sciences Centre
CollaboratorUNKNOWN
Centre hospitalier de l'Université de Montréal (CHUM)
CollaboratorOTHER
Jewish General Hospital
CollaboratorOTHER
Montreal General Hospital
CollaboratorOTHER
Royal Victoria Hospital, Canada
CollaboratorOTHER
Maisonneuve-Rosemont Hospital
CollaboratorOTHER
St Mary's Hospital, London
CollaboratorOTHER
Centre Hospitalier Pierre Boucher
CollaboratorUNKNOWN
Cité de la Santé Hospital
CollaboratorUNKNOWN
Centre Hospitalier Anna Laberge
CollaboratorUNKNOWN
Hotel Dieu Hospital
CollaboratorOTHER
CHAUQ - Hopital Saint Sacrement and Hopital Enfant Jesus
CollaboratorUNKNOWN
CISSS de Chaudière-Appalaches
CollaboratorOTHER_GOV
Hamilton Health Sciences Corporation
CollaboratorOTHER
Unity Health Toronto
CollaboratorOTHER
Sunnybrook Health Sciences Centre
CollaboratorOTHER
Toronto General Hospital
CollaboratorOTHER
York Central Hospital, Ontario
CollaboratorOTHER
Lakeridge Health Corporation
CollaboratorOTHER
Guelph General Hospital
CollaboratorUNKNOWN
London Health Sciences Centre
CollaboratorOTHER
The Ottawa Hospital
CollaboratorOTHER
Kingston Health Sciences Centre
CollaboratorOTHER
Scarborough General Hospital
CollaboratorOTHER
Matsqui-Sumas-Abbotsford General Hospital and Mission Memorial Hospital
CollaboratorUNKNOWN
Vancouver General Hospital
CollaboratorOTHER
Peter Lougheed Centre
CollaboratorOTHER
Foothills Medical Centre
CollaboratorOTHER
Alberta Health services
CollaboratorOTHER
Grey Nuns Hospital
CollaboratorUNKNOWN
University of Alberta
CollaboratorOTHER
Royal Alexandra Hospital
CollaboratorOTHER
Misericordia
CollaboratorUNKNOWN
Royal University Hospital Foundation
CollaboratorOTHER
Regina General Hospital
CollaboratorOTHER
University of Manitoba
CollaboratorOTHER
McGill University Health Centre/Research Institute of the McGill University Health Centre
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age 18 or over. * Treated during the study duration * Primary or secondary discharge diagnoses of NVUGIB (per charted ICD-10 code). Additional confirmation of NVUGIB using endoscopic findings or patient symptoms done as previous.

Exclusion criteria

* Patients initially assessed at another institution for the present episode of NVUGIB and subsequently transferred to the participating site with unavailable initial data. * Endoscopy noted no gastro-duodenal ulcer bleeding, to ensure patient homogeneity.

Design outcomes

Primary

MeasureTime frame
Adherence to guidelines G10 and G17 of the 2003 International Consensus Guidelines on nonvariceal upper GI bleeding.1 year

Secondary

MeasureTime frame
Adherence to guidelines G10 or G17 alone, G5b, G6, G7a, G7b , G7c, G18 of the 2003 International Consensus Conference on nonvariceal upper GI bleeding.1 year

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026